Update from Seattle: the 9th Annual Retrovirus Conference.
Laurence
Jeffrey
J
D016915:AIDS Vaccines / Q000276:immunology* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D003497:Cyclic N-Oxides / Q000494:pharmacology / Q000627:therapeutic use; D006678:HIV / Q000737:chemistry / Q000187:drug effects / Q000276:immunology* / Q000502:physiology; D015658:HIV Infections / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D010091:Oximes; D010880:Piperidines; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use; D012190:Retroviridae / Q000502:physiology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D017211:Treatment Failure; D014861:Washington
D016915:AIDS Vaccines; D003497:Cyclic N-Oxides; D010091:Oximes; D010880:Piperidines; D011725:Pyridines; C438583:Ancriviroc